158 related articles for article (PubMed ID: 11263438)
41. CD38 as a prognostic marker in CLL.
Matrai Z
Hematology; 2005 Feb; 10(1):39-46. PubMed ID: 16019444
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
Xiao M; Oppenlander BK; Dooley DC
Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
[TBL] [Abstract][Full Text] [Related]
43. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
44. Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.
Bharadwaj M; Burrows SR; Burrows JM; Moss DJ; Catalina M; Khanna R
Blood; 2001 Oct; 98(8):2588-9. PubMed ID: 11665684
[No Abstract] [Full Text] [Related]
45. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer.
Shubinsky G; Schlesinger M
Immunity; 1997 Sep; 7(3):315-24. PubMed ID: 9324352
[No Abstract] [Full Text] [Related]
46. [CD38 antigen (ADP-ribosyl cyclase) and secretory mechanism of insulin].
Taminato T; Ito T; Kato H
Nihon Rinsho; 1997 Nov; 55 Suppl():880-7. PubMed ID: 9434581
[No Abstract] [Full Text] [Related]
47. CD38 in T- and B-cell functions.
Deterre P; Berthelier V; Bauvois B; Dalloul A; Schuber F; Lund F
Chem Immunol; 2000; 75():146-68. PubMed ID: 10851783
[No Abstract] [Full Text] [Related]
48. Purification and characterization of CD38/ADP-ribosyl cyclase from rat lung.
Khoo KM; Chang CF
Biochem Mol Biol Int; 1998 Apr; 44(4):841-50. PubMed ID: 9584998
[TBL] [Abstract][Full Text] [Related]
49. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
50. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
51. Schematic portrait of human CD38 and related molecules.
Funaro A; Ferrero E; Mehta K; Malavasi F
Chem Immunol; 2000; 75():256-73. PubMed ID: 10851789
[TBL] [Abstract][Full Text] [Related]
52. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
[TBL] [Abstract][Full Text] [Related]
53. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
54. Relationship between cell surface expression of CD38 and of vascular endothelial growth factor in B-cell chronic lymphocytic leukemia.
McCabe D; O'Regan K; Murphy PT
Leuk Res; 2004 Nov; 28(11):1239-40. PubMed ID: 15380351
[No Abstract] [Full Text] [Related]
55. Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction.
Raaijmakers MH; van Emst L; de Witte T; Mensink E; Raymakers RA
Exp Hematol; 2002 May; 30(5):481-7. PubMed ID: 12031655
[TBL] [Abstract][Full Text] [Related]
56. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
[No Abstract] [Full Text] [Related]
57. CD34+CD38-HLA-DR- correlate more closely than CD34+CD38- with engraftment post-PBSC transplantation.
Drake M; Ranaghan EA; Alexander HD; Desai ZR; Morris TC
Br J Haematol; 1999 Mar; 104(3):643-4. PubMed ID: 10086811
[No Abstract] [Full Text] [Related]
58. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
59. Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production.
Mentz F; Merle-Beral H; Dalloul AH
Leukemia; 1999 Jan; 13(1):78-84. PubMed ID: 10049064
[TBL] [Abstract][Full Text] [Related]
60. The making of a leukocyte receptor: origin, genes and regulation of human CD38 and related molecules.
Ferrero E; Saccucci F; Malavasi F
Chem Immunol; 2000; 75():1-19. PubMed ID: 10851776
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
